Skip to main content
. 2016 Dec 22;8(5):8143–8153. doi: 10.18632/oncotarget.14106

Figure 3.

Figure 3

18F-FDG PET/CT images before A and after B treatment showed a reduction of FDG uptake with a ΔSUVmax of 96.67% classifying the patient as responder.